Expanding the clinical spectrum of intellectual disability associated with MECP2 duplication
Nội dung chính của bài viết
Tóm tắt
Xq28 duplication or MECP2 duplication syndrome (MDS) is a rare X-linked genetic disorder characterized by intellectual disability (ID), neurodevelopmental disorders (NDDs), recurrent respiratory infections, abnormal facial features, and progressive neurological decline. Several challenges exist in the clinical identification of MDS, particularly given that most male patients inherited the chromosomal abnormality from asymptomatic or mildly symptomatic carrier mothers. The objective of our familial case series was to provide a clinical description of four males with intellectual disability across two generations in a Vietnamese family with MECP2 duplication syndrome. Chromosomal microarray analysis (CMA) was used to confirm the molecular abnormality and its segregation within the family. This familial case series illustrates typical and variable manifestations of MDS, especially changes observed from the fetal to the neonatal and adolescent period, which is essential, especially in diseases reported as progressive neurological decline, such as MECP2.
Chi tiết bài viết
Từ khóa
MECP2 duplication syndrome, intellectual disability, duplication
Tài liệu tham khảo
2. Lewis JD, Meehan RR, Henzel WJ, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA. Cell. 1992; 69(6): 905-914. doi:10.1016/0092-8674(92)90610-O.
3. Bajikar SS, Anderson AG, Zhou J, et al. MeCP2 regulates Gdf11, a dosage-sensitive gene critical for neurological function. eLife. 12:e83806. doi:10.7554/eLife.83806.
4. Dominguez G, Wu Y, Zhou J. Epigenetic Regulation and Neurodevelopmental Disorders: From MeCP2 to the TCF20/PHF14 Complex. Genes (Basel). 2024; 15(12): 1653. doi:10.3390/genes15121653.
5. Gulmez Karaca K, Brito DVC, Oliveira AMM. MeCP2: A Critical Regulator of Chromatin in Neurodevelopment and Adult Brain Function. International Journal of Molecular Sciences. 2019; 20(18): 4577. doi:10.3390/ijms20184577.
6. Asuncion RMD, Ramani PK. Rett Syndrome. In: StatPearls. eBook. StatPearls Publishing; 2025. Accessed October 10, 2025. http://www.ncbi.nlm.nih.gov/books/NBK482252/.
7. Kaur S, Christodoulou J. MECP2 Disorders. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. eBook. University of Washington, Seattle; 1993. Accessed October 10, 2025. http://www.ncbi.nlm.nih.gov/books/NBK1497/.
8. Van Esch H. MECP2 Duplication Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. eBook. University of Washington, Seattle; 1993. Accessed September 10, 2025. http://www.ncbi.nlm.nih.gov/books/NBK1284/.
9. El Chehadeh S, Touraine R, Prieur F, et al. Xq28 duplication including MECP2 in six unreported affected females: what can we learn for diagnosis and genetic counselling? Clin Genet. 2017; 91(4): 576-588. doi:10.1111/cge.12898.
10. Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020; 22(2): 245-257. doi:10.1038/s41436-019-0686-8.
11. Ta D, Downs J, Baynam G, Wilson A, Richmond P, Leonard H. A brief history of MECP2 duplication syndrome: 20-years of clinical understanding. Orphanet J Rare Dis. 2022; 17(1): 131. doi:10.1186/s13023-022-02278-w.
12. Yon DK, Park JE, Kim SJ, Shim SH, Chae KY. A sibship with duplication of Xq28 inherited from the mother; genomic characterization and clinical outcomes. BMC Med Genet. 2017; 18(1): 30. doi:10.1186/s12881-017-0394-7.
13. Marafi D, Suter B, Schultz R, Glaze D, Pavlik VN, Goldman AM. Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome. Neurology. 2019; 92(2): e108-e114. doi:10.1212/WNL.0000000000006742.
14. Takeguchi R, Takahashi S, Akaba Y, et al. Early diagnosis of MECP2 duplication syndrome: Insights from a nationwide survey in Japan. Journal of the Neurological Sciences. 2021; 422. doi:10.1016/j.jns.2021.117321.
15. Reardon W, Donoghue V, Murphy AM, et al. Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28. Eur J Pediatr. 2010; 169(8): 941-949. doi:10.1007/s00431-010-1144-4.
16. Pehlivan D, Bengtsson JD, Bajikar SS, et al. Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression. Genome Med. 2024; 16(1): 146. doi:10.1186/s13073-024-01411-7.
17. Carvalho CMB, Zhang F, Liu P, et al. Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum Mol Genet. 2009; 18(12): 2188-2203. doi:10.1093/hmg/ddp151.
18. Clinical Genome Resource (ClinGen). Xq28 region (includes MECP2) curation results for dosage sensitivity. ClinGen Dosage Sensitivity Map. Accessed October 10, 2025. https://search.clinicalgenome.org/kb/gene-dosage/region/ISCA-46304.
19. University of California, Santa Cruz (UCSC) Genome Browser. Human hg38 chrX:153594028-154140741 (v488). UCSC Genome Browser Database. Accessed October 10, 2025. https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&position=chrX%3A153594028-154140741.